testosterone enanthate has been researched along with Kallmann Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sarfati, J; Saveanu, A; Young, J | 1 |
| Ishizaka, K; Kageyama, Y; Kihara, K; Suzuki, M; Yoshida, K | 1 |
2 other study(ies) available for testosterone enanthate and Kallmann Syndrome
| Article | Year |
|---|---|
Pituitary stalk interruption and olfactory bulbs aplasia/hypoplasia in a man with Kallmann syndrome and reversible gonadotrope and somatotrope deficiencies.
Topics: Azoospermia; Gonadotropins; Human Growth Hormone; Humans; Kallmann Syndrome; Male; Olfactory Bulb; Pituitary Gland; Testis; Testosterone; Young Adult | 2015 |
Bone mineral density in hypogonadal men remains low after long-term testosterone replacement.
Topics: Adult; Age Factors; Bone Density; Cryptorchidism; Hormone Replacement Therapy; Humans; Hypogonadism; Injections, Intramuscular; Kallmann Syndrome; Male; Middle Aged; Reference Values; Testosterone | 2002 |